Cardiac light-chain deposition disease and hints at diagnosing: a case report
暂无分享,去创建一个
[1] O. Pfister,et al. Nonamyloidotic light chain deposition cardiomyopathy. , 2021, European Heart Journal-Cardiovascular Imaging.
[2] M. Copin,et al. Paraffin Immunofluorescence Increases Light-Chain Detection in Extra-Renal Light Chain Amyloidosis and Other Light-Chain-Associated Diseases. , 2020, Archives of pathology & laboratory medicine.
[3] S. Plein,et al. Cardiac T1 Mapping and Extracellular Volume (ECV) in clinical practice: a comprehensive review , 2016, Journal of Cardiovascular Magnetic Resonance.
[4] N. Gokden,et al. A Case of Cardiac Light Chain Deposition Disease in a Patient with Solitary Plasmacytoma , 2016, The American journal of case reports.
[5] C. Kim,et al. A Case of Cardiac Dysfunction Associated with Monoclonal Gammopathy of Undetermined Significance , 2009, Journal of Korean medical science.
[6] F. Locatelli,et al. Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[7] T. Masuda,et al. Reversible restrictive cardiomyopathy due to light-chain deposition disease. , 2002, Mayo Clinic proceedings.
[8] I. Kronzon,et al. Infiltrative Nonamyloidotic Monoclonal Immunoglobulin Light Chain Cardiomyopathy: An Underappreciated Manifestation of Plasma Cell Dyscrasias , 2000, Cardiology.
[9] L. Denoroy,et al. Overrepresentation of the V kappa IV subgroup in light chain deposition disease. , 1994, Immunology letters.
[10] M. Cogné,et al. Structure of a monoclonal kappa chain of the V kappa IV subgroup in the kidney and plasma cells in light chain deposition disease. , 1991, The Journal of clinical investigation.